Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | -68.59%2.48M | 134.75%7.9M | 290.42%3.36M | -1.77M |
| Net profit before non-cash adjustment | -79.16%1.04M | 196.33%4.99M | 736.46%1.68M | ---264.32K |
| Total adjustment of non-cash items | 34.62%5.02M | 31.36%3.73M | 160.85%2.84M | --1.09M |
| -Depreciation and amortization | 31.74%2.93M | 47.88%2.22M | 127.21%1.5M | --661.03K |
| -Reversal of impairment losses recognized in profit and loss | 29.76%109K | --84K | --0 | --0 |
| -Disposal profit | 607.14%71K | ---14K | --0 | ---- |
| -Other non-cash items | 33.10%1.91M | 7.56%1.44M | 212.90%1.34M | --427.28K |
| Changes in working capital | -337.00%-3.58M | 29.27%-819K | 55.29%-1.16M | ---2.59M |
| -Change in receivables | -1,015.67%-4.49M | 63.19%-402K | 0.25%-1.09M | ---1.09M |
| -Change in inventory | 336.36%468K | 77.34%-198K | -399.16%-873.67K | ---175.03K |
| -Change in payables | 300.00%438K | -127.11%-219K | 161.19%807.85K | ---1.32M |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | ||||
| Interest paid (cash flow from operating activities) | ||||
| Interest received (cash flow from operating activities) | ||||
| Tax refund paid | -105.71%-2.2M | -27.81%-1.07M | -232.02%-835.6K | -251.67K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 |
| Operating cash flow | -95.85%283K | 170.10%6.83M | 225.26%2.53M | ---2.02M |
| Investing cash flow | ||||
| Net PPE purchase and sale | 18.18%-6.95M | 37.55%-8.49M | 47.71%-13.59M | ---26M |
| Net intangibles purchase and sale | 94.71%-64K | ---1.21M | --0 | ---- |
| Net business purchase and sale | ---- | --0 | --0 | ---- |
| Net investment product transactions | 33.33%-2K | ---3K | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | --0 | --0 | --0 |
| Interest received (cash flow from investment activities) | 0.00%7K | 394.70%7K | -96.46%1.42K | --39.99K |
| Net changes in other investments | ---- | 97.49%-2.51K | ---100K | ---- |
| Investing cash flow | 27.74%-7M | 29.20%-9.69M | 47.25%-13.69M | ---25.96M |
| Financing cash flow | ||||
| Net issuance payments of debt | 630.08%7.88M | -119.16%-1.49M | -50.33%7.76M | --15.62M |
| Net common stock issuance | --0 | -85.56%1.4M | --9.7M | --0 |
| Increase or decrease of lease financing | ---- | 7.39%-227.82K | -50.42%-246.01K | ---163.55K |
| Interest paid (cash flow from financing activities) | -10.19%-1.83M | -31.34%-1.66M | -159.58%-1.26M | ---486.61K |
| Net other fund-raising expenses | -200.00%-40K | 451.49%40K | -186.87%-11.38K | --13.1K |
| Financing cash flow | 452.64%6.01M | -110.69%-1.7M | 6.39%15.94M | --14.98M |
| Net cash flow | ||||
| Beginning cash position | -80.67%1.1M | 534.67%5.67M | -93.57%892.59K | --13.89M |
| Current changes in cash | 84.42%-712K | -195.75%-4.57M | 136.73%4.77M | ---12.99M |
| End cash Position | -65.02%383K | -80.67%1.1M | 534.70%5.67M | --892.59K |
| Free cash flow | -135.02%-6.87M | 73.60%-2.92M | 60.50%-11.07M | ---28.01M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.